Pricola, Katie L <br/><br/>
Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism.  [electronic resource] 

 -  Journal of cellular biochemistry  Oct 2009 
 - 577-88 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1097-4644 
<br/><br/><label>Standard No.: </label>10.1002/jcb.22289  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Apoptosis--drug effects<br/>Bone Marrow Cells--cytology<br/>Butadienes--pharmacology<br/>Cell Differentiation--drug effects<br/>Cell Proliferation--drug effects<br/>Culture Media, Serum-Free<br/>Cytoprotection--drug effects<br/>Down-Regulation--drug effects<br/>Enzyme Activation--drug effects<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Gene Knockdown Techniques<br/>Humans<br/>Interleukin-6--genetics<br/>Mesenchymal Stem Cells--cytology<br/>Middle Aged<br/>Nitriles--pharmacology<br/>RNA, Small Interfering--metabolism<br/>STAT3 Transcription Factor--metabolism<br/>Wound Healing--drug effects